Clinical Trial Update: Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing obinutuzumab plus venetoclax versus obinutuzumab plus chlorambucil in chronic lymphocytic leukemia; the study is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Obinutuzumab (obinutuzumab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2019-10-01